EFTISARC-NEO - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

NLC India is seeking 1,500 acres of private land for utility-scale solar projects in Tamil Nadu, implying around 300 MW of initial capacity with potential expansion to roughly 600 MW under a green-shoe option. Representative image.

PowerBank (NASDAQ: PBK) clears permit for C$14m Nova Scotia solar project

Continental Resources is expanding its Permian Basin footprint through the acquisition of FireBird Energy II, adding about 54,000 net Midland Basin acres and 32,000 barrels of oil equivalent per day of production, including a 69% oil mix. Representative image.

Continental Resources to buy FireBird as Permian footprint grows more than 40%

Mitsubishi Electric Corporation’s $1.4 billion acquisition of PCI Energy Solutions expands its push into power-market software as utilities manage increasingly complex grids shaped by renewables, battery storage and rising electricity demand. Representative image.

Mitsubishi Electric’s $1.4bn PCI deal targets software managing 60% of US power

Johan Sverdrup crude could meet 25% of ORLEN demand under three-year agreement

Equinor strikes three-year ORLEN deal for up to 9m tonnes of crude a year

Read More

Pharma Industry News

Immutep (ASX: IMM) surges 48% on FDA orphan drug designation: Is the STS pivot the new thesis?

Immutep (ASX: IMM) jumped 48% after the FDA granted orphan drug status for eftilagimod alfa in soft tissue sarcoma. Here is what the EFTISARC-NEO data means for the investment case.

April 15, 2026

web analytics